Studying kidney transplant outcomes with deep tissue analysis
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks closely at kidney tissue after transplant to predict how well the organ will work over time. Researchers hope this will help improve long-term care for transplant recipients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a kidney transplant from a living or deceased donor.
- You are 18 years or older.
- You can understand and agree to join the study.
- You are not on blood thinners or have a low platelet count that would make a biopsy unsafe.
- Your kidney failure was not due to a condition called hemolytic uremic syndrome (HUS) that can come back in the new kidney.
- You are taking standard transplant medications (thymoglobulin, tacrolimus, and mycophenolate).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body’s immune system responds when a kidney transplant shows signs of rejection, using a planned kidney biopsy. It may help doctors better understand what drives rejection and how to improve care in the future.
This study looks at tissue samples from kidney transplant patients who have a specific type of long-term rejection called chronic active humoral rejection (cAMR). It aims to better understand the condition and help future patients.
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study is looking at how genes affect kidney transplant outcomes. It asks you to give extra blood, urine, stool, and kidney tissue samples over time, so researchers can learn more about why some transplants work better than others.
Hear when a new Renal Transplant Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.